Fair Value Calculator Fair Value Calculator
EN DE

SHARIKA (SHARIKA) Fair Value & Analysis

IN · Market cap ₹818M

S SHARIKA SHARIKA · BSE
Price₹18.88
Fair Value₹2.06
Upside-89.1%
Quality39/100
Watch SHARIKA for free — get notified when fair value or trend changes. Watch for free
Evidence: Low Range ₹1.53 – ₹3.07

Fair value as of: Jul 6, 2026

From 1 valuation models · updated today

Share price +30.6% over the past month.

Price vs Fair Value (12 months)

₹21.93 ₹9.02 Fair Value ₹2.06 Jul 2025 Jul 2026

12‑month range ₹9.02 – ₹21.93 · fair‑value band ₹1.53 – ₹3.07 · the ₹18.88 price screens above the ₹2.06 fair value. As of Jul 6, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

SHARIKA (SHARIKA) currently trades at ₹18.88, while our model-based Fair Value estimate is ₹2.06 — implying the stock looks roughly 89.1% overvalued today. We read business quality at 39/100 (below-average quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Over the trailing twelve months, SHARIKA generated revenue of ₹755M at a net margin of -11.7%. Revenue grew 20.9% year over year. It earns a return on equity of -50.6%. Net debt stands at ₹255M. Fundamentals as of Jul 6, 2026

Our scenario range runs from ₹1.53 (bear case) to ₹3.07 (bull case); at ₹18.88, the current price sits above that range. The share trades about 14% below its 52-week high and 129% above its 52-week low, currently above its 200-day average.

Key figures & financial health

Revenue (TTM) ₹755M
Revenue growth (YoY) +20.9%
Net margin -11.7%
Return on equity -50.6%
Free cash flow −₹74.1M FY2025
Operating margin -14.2%
More key figures
EPS (TTM) ₹-2.04
EPS growth (YoY) -33.2%
Net debt ₹255M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 6, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

SHARIKA reported revenue of ₹755M in FY2025 versus ₹392M in FY2021, a compound +17.8%/yr. Reported net income was −₹88.5M in FY2025.

Revenue +17.8%/yr
FY21 ₹392M
FY22 ₹504M
FY23 ₹784M
FY24 ₹817M
FY25 ₹755M
Net income
FY21 ₹8.4M
FY22 −₹33.2M
FY23 ₹15.3M
FY24 −₹3.6M
FY25 −₹88.5M

Is SHARIKA fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "SHARIKA Fair Value". https://www.fairvalue-calculator.com/stock/SHARIKA

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is SHARIKA (SHARIKA) undervalued?
As of Jul 6, 2026, our model estimates a fair value of ₹2.06 versus a price of ₹18.88 — about −89% (overvalued). Model-based estimate, not financial advice.
What is the fair value of SHARIKA?
Our model-based fair value for SHARIKA is ₹2.06 (as of Jul 6, 2026), built from audited fundamentals. The current price is ₹18.88.
What is the quality score of SHARIKA?
SHARIKA has a Quality Score of 39/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of SHARIKA (SHARIKA)?
SHARIKA reported trailing-twelve-month revenue of about ₹755M (latest available figure, as of Jul 6, 2026).
What is the net profit margin of SHARIKA?
The net profit margin of SHARIKA is about -11.7%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.